GO:0006915 BP 1.33e-07    9/45   547/29107 D04 apoptotic process                        388.0, 1263.0, 4616.0, 4792.0, 5272.0, 5292.0, 5359.0, 5552.0, 64651.0 
GO:0071222 BP 2.21e-07    7/45   167/29107 D06 cellular response to lipopolysaccharide  2919.0, 2920.0, 3576.0, 5054.0, 7133.0, 7538.0, 57817.0 
GO:0043066 BP 6.82e-07   10/45   483/29107 D07 negative regulation of apoptotic process 602.0, 1026.0, 1263.0, 4170.0, 4609.0, 5272.0, 5292.0, 5329.0, 7057.0, 9021.0 
GO:0045944 BP 7.02e-07   11/45  1106/29107 D11 positive regulation of transcription by RNA polymerase II 602.0, 1052.0, 1316.0, 4609.0, 4792.0, 5187.0, 5359.0, 5966.0, 23764.0, 57817.0, 64651.0 
GO:0006935 BP 8.71e-07    5/45   113/29107 D03 chemotaxis                               2357.0, 2919.0, 2920.0, 3576.0, 5329.0 
GO:0006954 BP 2.04e-06    7/45   387/29107 D04 inflammatory response                    2357.0, 2919.0, 2920.0, 3576.0, 5966.0, 7057.0, 7133.0 
GO:0071356 BP 2.17e-06    5/45   136/29107 D06 cellular response to tumor necrosis factor 3576.0, 7057.0, 7538.0, 8531.0, 57817.0 
GO:0060325 BP 1.23e-05    3/45    29/29107 D03 face morphogenesis                       25976.0, 64651.0, 83716.0 
GO:0001525 BP 2.96e-05    5/45   233/29107 D03 angiogenesis                             388.0, 3576.0, 5054.0, 6303.0, 81575.0 
GO:0051726 BP 3.09e-05    5/45   235/29107 D04 regulation of cell cycle                 1026.0, 3576.0, 4609.0, 4616.0, 7057.0 
GO:0010757 BP 3.49e-05    2/45     6/29107 D10 negative regulation of plasminogen activation 5054.0, 7057.0 
GO:0007249 BP 4.37e-05    3/45    44/29107 D06 I-kappaB kinase/NF-kappaB signaling      602.0, 4792.0, 5966.0 
GO:0005634 CC 7.39e-07   25/45  5368/29107 D05 nucleus                                  388.0, 602.0, 639.0, 1026.0, 1263.0, 1316.0, 4170.0, 4609.0, 4616.0, 4739.0, 4792.0, 5187.0, 5272.0, 5292.0, 5359.0, 5966.0, 7133.0, 7538.0, 8531.0, 10865.0, 23764.0, 25976.0, 57018.0, 57817.0, 64651.0 
GO:0005654 CC 2.64e-05   17/45  3805/29107 D02 nucleoplasm                              602.0, 639.0, 1026.0, 1052.0, 1263.0, 1316.0, 4170.0, 4609.0, 4739.0, 4792.0, 5187.0, 5272.0, 5292.0, 5359.0, 5966.0, 10865.0, 23764.0 
GO:0005515 MF 1.03e-06   39/45 12418/29107 D02 protein binding                          388.0, 602.0, 639.0, 1026.0, 1052.0, 1263.0, 1316.0, 2012.0, 2357.0, 2919.0, 2920.0, 3576.0, 4170.0, 4609.0, 4616.0, 4739.0, 4792.0, 5054.0, 5187.0, 5272.0, 5292.0, 5329.0, 5359.0, 5552.0, 5966.0, 6303.0, 7057.0, 7133.0, 7538.0, 8531.0, 9021.0, 9123.0, 10797.0, 10865.0, 23764.0, 57018.0, 64651.0, 79845.0, 85450.0 
GO:0045236 MF 1.55e-06    3/45    15/29107 D06 CXCR chemokine receptor binding          2919.0, 2920.0, 3576.0 
GO:0001228 MF 5.04e-06    7/45   444/29107 D04 DNA-binding transcription activator activity, RNA polymerase II-specific 1052.0, 1316.0, 4609.0, 5359.0, 5966.0, 23764.0, 64651.0 
GO:0004860 MF 1.82e-05    3/45    33/29107 D05 protein kinase inhibitor activity        1026.0, 9021.0, 85450.0 
